Haemophilus Influenzae Type Infection
📧 Sign up to get email alerts when something new happens for Haemophilus Influenzae Type Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine [Phase 3]
A Phase 3 study evaluated the safety of two combination vaccines (DTPa-IPV/Hib and DTPa-HBV-IPV/Hib) in infants who had received hepatitis B…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of a monovalent glycoprotein-conjugated Hib vaccine (Diphtheria toxin CRM197) in heal…
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children [Phase 4]
A Phase 4 safety study evaluating Haemophilus influenzae type b vaccine in Korean children has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age [Phase 3]
A Phase 3 study assessing the safety and reactogenicity of GlaxoSmithKline's DTPa/Hib vaccine administered at 3, 4, and 5 months of age has …
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants [Phase 3]
The document reports Phase 3 results evaluating lot-to-lot consistency of Tritanrix-HepB/Hib-MenAC and its non-inferiority compared with Tri…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine [Phase 3]
Phase 3 trial in infants demonstrates non-inferiority, persistence, and immunogenicity of the Hib-MenC vaccine.
-
CLINICAL_TRIALS research · 2016-09-29Clinical Trial Update: Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age [Phase 1, Phase 2]
This clinical trial update reports on the immunogenicity and safety of a combined meningococcal A/C and Haemophilus influenzae type b conjug…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine [Phase 3]
A Phase 3 immunogenicity study comparing GlaxoSmithKline's Hib-MenC conjugate vaccine to a licensed meningococcal C vaccine; it assesses pri…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. [Phase 3]
A Phase 3 immunogenicity and safety study of an infant meningitis vaccine given after a hepatitis B birth dose completed; the trial evaluate…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects [Phase 3]
A Phase 3 trial comparing a Hib-MenC conjugate booster vaccine against Infanrix Hexa in 14-month-old children. The study has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. [Phase 2]
Phase 2 trial by GlaxoSmithKline evaluated antibody persistence and booster response, as well as safety, in individuals previously primed wi…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™ [Phase 2]
Phase 2 trial comparing immunogenicity, safety, and reactogenicity of Tritanrix™-HepB/Hib2.5 versus Tritanrix™-HepB/Hiberix™ in Haemophilus …
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Phase III Study of Intramuscular TAK-816 in Healthy Infants [Phase 3]
Phase III trial evaluating intramuscular TAK-816 for prevention of Haemophilus influenzae type B disease in infants was completed; results w…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age [Phase 4]
Phase 4 clinical trial update on Menactra in healthy infants at 9 months and co-administered with Pentacel at 15-18 months; results have bee…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried [Phase 3]
Phase 3 clinical trial update assessing the safety and immunogenicity of a freeze-dried Haemophilus influenzae type b conjugate vaccine; spo…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Database Surveillance Safety Study of PENTACEL® Vaccine
Completed database surveillance safety study evaluating the Pentacel vaccine for safety signals related to its diphtheria, tetanus, pertussi…
-
CLINICAL_TRIALS research · 2015-07-28Clinical Trial Update: Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates [Phase 4]
Phase 4 clinical trial update from a French hospital on an immunisation schedule combining diphtheria, tetanus, poliomyelitis with Pertussis…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants [Phase 3]
Phase 3 trial comparing the safety and immunogenicity of Pediacel versus Infanrix IPV+Hib (Penta) given in a 3-dose schedule in infants; the…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® [Phase 3]
Phase 3 trial comparing booster vaccination with Pediacel versus Infanrix Hexa when co-administered with Prevenar in healthy infants has com…
-
FDA approval · 2014-08-21FDA Approved: RIFAMPIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's generic rifampin (RIFAMPIN) under an Original Application (ANDA), expanding access to this antibiotic…
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants [Phase 2]
A Phase 2 study evaluating GSK2197870A vaccine given as a primary course in infants has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject [Phase 3]
A Phase 3 clinical trial comparing the immunogenicity and safety of Quinvaxem vaccine given in mono-dose vials versus Uniject.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial update on safety and immunogenicity of new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (DTPa-HBV-IPV/Hib, GSK217744).
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants [Phase 3]
Phase 3 study assessing the immunogenicity and safety of a booster dose of the DTaP-IPV-HB-PRP~T combined vaccine in healthy Turkish infants…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-Hep B-PRP~T Combined Vaccine with Infanrix Hexa in healthy Peruvian infants; results were posted in 2014.